Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Clin Radiol ; 65(9): 685-94, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20696295

ABSTRACT

Many types of cardiac and pericardial calcifications identified on chest radiographs can be recognized and distinguished based on characteristic locations and appearances. The purpose of this review is to emphasize the importance of detecting cardiac and pericardial calcifications on chest radiographs, and to illustrate and describe the various types of calcifications that may be encountered and how they may be differentiated from one another. Each type of cardiac and pericardial calcification is discussed, its location and appearance described, and its significance explained. Recognizing and understanding these calcifications is important as they are often encountered in daily practice and play an important role in patient care.


Subject(s)
Calcinosis/diagnostic imaging , Cardiomyopathies/diagnostic imaging , Coronary Aneurysm/diagnostic imaging , Heart/diagnostic imaging , Radiography, Thoracic/methods , Cardiomyopathies/physiopathology , Coronary Aneurysm/physiopathology , Diagnosis, Differential , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Humans
2.
Oncogene ; 14(18): 2229-38, 1997 May 08.
Article in English | MEDLINE | ID: mdl-9174059

ABSTRACT

DNase I footprinting of the rat TGF alpha promoter in the presence of crude cell nuclear extract revealed three sites of protein-DNA interaction (Fp-A, Fp-B, Fp-C) in the region from -222 to +73. Mutation of specific sites within the Fp-A and Fp-B regions reduced expression of a TGF alpha promoter-reporter gene (TGF alphaLUC) from 50-90% in transiently transfected CHO cells, indicating the importance of protein/DNA interactions at these sites. Since Fp-A contained a perfect AP2 consensus sequence (5'-GCCNNNGGC-3') as its center, we investigated the possibility that AP2 binding is important for TGF alpha promoter activity. A double-stranded oligonucleotide spanning Fp-A displayed a distinct mobility shift in the presence of nuclear extract that was inhibited by an excess of known functional AP2-binding sequence. Moreover, a similar mobility shift occurred in the presence of purified AP2 protein, and the further addition of AP2 antibody produced a supershifted complex. More refined DNase I footprinting of a smaller, oligonucleotide probe in the presence of purified AP2 protein revealed a protected region that included the putative AP2 binding site. Additionally, co-transfection of an AP2 expression vector increased TGF alphaLUC expression 25-fold in Drosophila Schneider cells. These various findings corroborate a role for AP2 in TGF alpha promoter activity. The Fp-B region contains a T5 motif that has been previously suggested to function as an atypical TATA box. An Fp-B oligonucleotide displayed a specific gel mobility shift in the presence of a TATA binding protein (TBP)-TFIIA complex, and the further addition of TBP antibody produced a supershift. These results confirm that protein binding within Fp-B is functionally important, and they also indicate that the T5 motif functions as a TBP binding site.


Subject(s)
DNA-Binding Proteins/metabolism , Transcription Factors/metabolism , Transforming Growth Factor alpha/genetics , Transforming Growth Factor alpha/metabolism , Animals , Base Sequence , Binding Sites , CHO Cells/metabolism , Cell Line , Cell Line, Transformed , Cricetinae , DNA Footprinting , Drosophila/genetics , Drosophila/metabolism , Drosophila Proteins , Electrophoresis/methods , Epithelial Cells , Gene Expression Regulation , Liver/cytology , Molecular Sequence Data , Mutation , Promoter Regions, Genetic , Rats , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , TATA-Box Binding Protein , Transcription Factor AP-2 , Transcription Factor TFIIA
3.
Cell Growth Differ ; 7(9): 1271-82, 1996 Sep.
Article in English | MEDLINE | ID: mdl-8877107

ABSTRACT

The spontaneous mouse waved 1 (wa1) mutation is allelic with the transforming growth factor alpha (TGF-alpha) gene and produces phenotypes similar to those of TGF-alpha knockout mice. Here, we show that TGF-alpha mRNA and protein levels are measurable in wa1 tissues but reduced 5- to 30-fold relative to wild type. Because the wa1-coding sequence is identical to that of the normal mRNA, wa1 is not a null mutation. Nuclear run-on analyses revealed decreased transcription of the TGF-alpha gene in wa1 tissues, but the sequence of a 3.2-kb 5' flanking fragment containing the promoter was unaltered. Moreover, pulsed field gel electrophoresis analysis did not reveal alterations within 750 kb upstream or 350 kb downstream of the gene, and chromosome 6 was karyotypically normal. Hence, we speculate that the wa1 mutation may be subtle and/or reside at a greater distance from the TGF-alpha gene. TGF-alpha deficiency elicits a spectrum of variably penetrant eye anomalies in wa1 and knockout mice that are associated with open eyes at birth. We found that late-gestation wa1 and TGF-alpha-null embryos display a significant delay in eyelid closure, although the eyes of most embryos fuse prior to birth. In situ hybridization localized TGF-alpha expression to the advancing margins of the eyelid epithelium and epidermal growth factor receptor expression throughout the eyelid and corneal epithelia. These results suggest that eye problems observed in TGF-alpha-deficient adult mice arise from premature exposure and trauma to open eyes during or following parturition.


Subject(s)
Eyelids/embryology , Gene Expression Regulation, Developmental/physiology , Mutation/physiology , Transforming Growth Factor alpha/genetics , Amino Acid Sequence , Animals , Base Sequence , Brain Chemistry , Chromosome Aberrations , Cornea/metabolism , DNA, Complementary/genetics , Epithelium/chemistry , Epithelium/pathology , ErbB Receptors/genetics , Mice , Mice, Knockout , Mice, Mutant Strains , Molecular Sequence Data , Organ Specificity , Promoter Regions, Genetic/genetics , RNA, Messenger/analysis , Sequence Analysis, DNA , Transcription, Genetic
4.
Oncogene ; 12(9): 1991-2002, 1996 May 02.
Article in English | MEDLINE | ID: mdl-8649860

ABSTRACT

Although TGFalpha mRNA and protein are frequently elevated in neoplastic cells, neither the level at which deregulation occurs nor the mechanism(s) responsible have been well characterized. As a first step, we examined the induction of TGFalpha mRNA in two series of clonally-derived rat liver epithelial cell lines that were transformed either by exposure to chemical carcinogen or stable transfection of activated Ha-ras. We found that steady-state levels of TGFalpha mRNA in both series of transformed lines were induced 25- to 50-fold over those in the respective normal parental cells. This induction, which occurred without amplification of the TGF alpha gene, was accompanied by at least a five- to 10-fold increase in transcription along the entire length of the gene with no evidence of a transcriptional attenuation or arrest mechanism in the normal cells. Analysis of the TGFalpha promoter and flanking regions did not support a correlation between the extent of methylation and the level of expression, but did reveal several DNase I hypersensitive sites spanning from -14 to +8 kilobases. Two of these sites were differentially observed in cells displaying high and low TGFalpha gene transcription, while a third site correlated with TPA-induced expression. Finally, measurement of TGFalpha mRNA decay in the presence of Actinomycin D revealed a consistent 1.5- to 3.2-fold increase in the half-life of the TGFalpha transcript in the various transformed cell lines. These results indicate that transformation-mediated induction of TGFalpha gene expression in rat liver epithelial cells occurs through both transcriptional and post-transcriptional mechanisms, but is primarily the result of TGFalpha promoter activation.


Subject(s)
Liver/metabolism , RNA Processing, Post-Transcriptional , Transcription, Genetic , Transforming Growth Factor alpha/genetics , Animals , Cell Line , Cell Line, Transformed , Deoxyribonuclease I/metabolism , Epithelial Cells , Epithelium/metabolism , Liver/cytology , Promoter Regions, Genetic , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats
6.
Oncogene ; 9(11): 3179-87, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7936640

ABSTRACT

Transcription from the rat TGF alpha promoter initiates at two predominant sites (-188 and -58) in a G+C-rich region that does not contain TATA or CAAT motifs. Previous studies using transfected reporter constructs implicated the transcription factor Sp1 in active expression from the promoter, particularly from the -58 site (Chen et al., 1992; Shin et al., 1992). In the present report we have examined the functionality of two adjacent clusters of Sp1-like recognition sites that are located in the upstream portion of the promoter from -300 to -273. A double-stranded oligonucleotide, which spanned this region and contained the putative Sp1 elements, demonstrated similar gel-mobility shifts in the presence of both crude HeLa cells nuclear extract and pure Sp1 protein. Mutations that simultaneously altered several of the overlapping Sp1 elements significantly reduced the gel-mobility shift activity of this oligonucleotide probe and, when introduced into the promoter templates, inhibited transcription in vitro from the proximal -188 start site. To confirm the binding of protein to these sites in cells, we carried out an in vivo genomic footprinting analysis of this portion of the TGF alpha promoter in normal and transformed rat liver epithelial cell lines that express the endogenous gene at varying levels. This analysis revealed clear evidence of protein/DNA interaction at Sp1-like sites in the -300 and -273 region in cells actively expressing the gene but not in a normal, parental cell line that expressed very low levels of TGF alpha mRNA. Collectively, these results corroborate the functional importance of Sp1 binding elements in the -300 to -273 region, and together with previous findings, indicate that two clusters of Sp1 binding sites respectively determine levels of transcription from the -188 and -58 start sites. Our additional finding that Sp1 mRNA and protein were present at similar levels in normal and transformed cells that expressed the endogenous TGF alpha gene at markedly different levels, suggests that the activity of the TGF alpha promoter could be regulated via the accessibility of Sp1 protein.


Subject(s)
Promoter Regions, Genetic , Sp1 Transcription Factor/metabolism , Transforming Growth Factor alpha/genetics , Amino Acid Sequence , Animals , Base Sequence , Binding Sites , Cell Line , DNA/genetics , DNA/metabolism , HeLa Cells , Humans , Molecular Sequence Data , Mutation , Rats , Transcription, Genetic
8.
Mol Endocrinol ; 7(4): 507-14, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8502236

ABSTRACT

Expression of the very low density apolipoprotein II (apoVLDLII) gene in the chicken is absolutely dependent on estrogen. ApoVLDLII mRNA is expressed in the Leghorn male hepatoma (LMH) cell line in response to estrogen in completely defined medium. Addition of serum to these cultures results in a decrease in apoVLDLII mRNA. Data in this report demonstrate that 1 nM insulin has the same inhibitory effect as 10% serum. Insulin inhibits apoVLDLII mRNA in a dose-dependent manner; 100 fM insulin inhibits the estrogen-dependent response by 76%. After transfection of LMH cells with apoVLDLII sequences from an 8.9-kilobase (kb) genomic clone (pApo107) that contains the entire 2.9-kb coding sequence along with approximately 3 kb each of 5'- and 3'-flanking DNA, the estrogen-dependent expression of apoVLDLII mRNA from both the endogenous gene and transfected DNA is reduced by insulin. Furthermore, insulin reduces by more than 90% the estrogen-dependent expression from a chimeric construct, pApoCAT, which contains apoVLDLII sequences -900/+1455 cloned 5' of the bacterial chloramphenicol acetyltransferase (CAT) reporter gene. To determine the specificity of the response, expression of the pApoCAT construct was tested with insulin-like growth factor-I and insulin. Three hundred picomolar insulin inhibits the estrogen-mediated CAT activity by 50%. Insulin-like growth factor-I at this concentration has no effect or slightly increases the estrogen-dependent expression of pApoCAT, suggesting that the observed inhibitory action is mediated by the insulin receptor. Consequently, the LMH cells provide an excellent model system in which to study the molecular mechanism of insulin and estrogen interaction in the regulation of gene expression.


Subject(s)
Apolipoproteins/genetics , Estrogens/pharmacology , Gene Expression/drug effects , Insulin/pharmacology , Lipoproteins, VLDL/genetics , Liver Neoplasms, Experimental/metabolism , Animals , Base Sequence , Blood , Chickens , Dose-Response Relationship, Drug , Insulin/administration & dosage , Insulin-Like Growth Factor I/pharmacology , Male , Molecular Sequence Data , RNA, Messenger/metabolism , Recombinant Fusion Proteins/genetics , Transfection , Tumor Cells, Cultured
9.
In Vitro Cell Dev Biol ; 28A(6): 391-6, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1634438

ABSTRACT

The estrogen-responsive Leghorn strain M chicken hepatoma (LMH) cell line provides a model system for studying the estrogen-dependent, liver-specific expression of avian genes. Serum-free culture conditions have been established that allow expression of apolipoprotein B, very low density apolipoprotein II (apoVLDLII), serum albumin, and transferrin at levels detectable by Northern blot analysis. Regulation of apoVLDLII mRNA by estrogen occurred in an appropriate time- and dose-dependent manner in serum-free cultures of the LMH cells. The expression of apoVLDLII mRNA in serum-free culture was at least 100-fold higher than that expressed in cultures containing 10% serum. The level of estrogen receptors in LMH cells cultured with 10% serum was approximately 2000 receptors per cell, and in serum-free culture approximately 1000 receptors per cell. When these cells were transfected with estrogen receptor DNA and cultured in serum-free medium, apoVLDLII mRNA was decreased relative to that expressed in cells transfected with a control plasmid. These results indicate that when the LMH cells are cultured without serum, estrogen receptors are not the limiting factor for the expression of the apoVLDLII gene.


Subject(s)
Apolipoprotein A-II/genetics , Estrogens/pharmacology , Gene Expression Regulation, Neoplastic/drug effects , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/pathology , Animals , Blotting, Northern , Chickens , Culture Media, Serum-Free , Dose-Response Relationship, Drug , Liver Neoplasms, Experimental/ultrastructure , RNA, Messenger/analysis , RNA, Messenger/genetics , Receptors, Estrogen/analysis , Serum Albumin/genetics , Transferrin/genetics , Tumor Cells, Cultured/chemistry , Tumor Cells, Cultured/pathology , Tumor Cells, Cultured/ultrastructure
10.
J Biol Chem ; 267(10): 7134-8, 1992 Apr 05.
Article in English | MEDLINE | ID: mdl-1372608

ABSTRACT

Estrogen regulates the expression of the yolk protein genes in the chicken liver during periods of egg laying. While all five of these genes, vitellogenins I, II, and III, very low density apolipoprotein II (apo VLDLII), and apolipoprotein B, respond to estrogen, individual controls are superimposed on their coordinate regulation with respect to the kinetics of induction, magnitude of response, and developmental expression. The estrogen-responsive Leghorn strain M hepatoma (LMH) cell line provides a model system for studying the molecular basis of the similarities and differences in the regulation of these genes. The apoVLDLII gene is regulated by estrogen in LMH cells in an appropriate time- and dose-dependent manner. Regulatory regions of the apoVLDLII gene have been identified by transient transfection studies in LMH cells. All four of the sequences previously shown to bind protein between the TAATA motif at -26 and proximal estrogen response element at -171 are essential in regulation of the apoVLDLII gene. Mutation of any single binding region reduces expression by more than 80%, indicating cooperative interactions of proteins across the entire region. While these sequences will direct assembly of a functional transcription complex, we demonstrate that addition of the first intron of the apoVLDLII gene to the promoter construct results in a 4-fold increase in estrogen-dependent expression following transient transfection into LMH cells. Results of deletion analyses indicate that two distinct regions of the intron contribute to this regulation.


Subject(s)
Apolipoproteins/genetics , Estrogens/pharmacology , Introns , Lipoproteins, VLDL/genetics , Protein Precursors/genetics , Animals , Base Sequence , Chickens , Chloramphenicol O-Acetyltransferase/genetics , Chloramphenicol O-Acetyltransferase/metabolism , Gene Expression , Liver/drug effects , Liver/metabolism , Molecular Sequence Data , Mutation , Plasmids , Promoter Regions, Genetic , RNA/genetics , RNA Splicing , Recombinant Fusion Proteins/genetics , Regulatory Sequences, Nucleic Acid , Restriction Mapping , Transfection
SELECTION OF CITATIONS
SEARCH DETAIL
...